business

CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio Revamp

Forbes · May 14, 2026, 1:24 PM · Also reported by 1 other source

A bankruptcy court has approved the sale of CVS Health’s underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.

Read full story on Forbes → More top stories

Also covered by

Yahoo Finance Do You Believe in the Long-Term Growth Potential of IDEXX Laboratories (IDXX)?

Aggregated and edited by the Scoop newsroom. We surface news from Forbes alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio Revamp

Also covered by

More in business